Editas Medicine (NASDAQ:EDIT) Releases Quarterly Earnings Results, Hits Expectations
Editas Medicine (NASDAQ:EDIT – Get Free Report) issued its earnings results on Monday. The company reported ($0.75) EPS for the quarter, hitting analysts’ consensus estimates of ($0.75), Briefing.com reports. The firm had revenue of $0.06 million during the quarter, compared to the consensus estimate of $3.93 million. Editas Medicine had a negative net margin of […]
7 Nov 02:54 · The Markets Daily